Maternal depression treatment in HIV (M-DEPTH) Study protocol for a cluster randomized controlled trial

dc.contributor.authorWagner, Glenn J.
dc.contributor.authorMcBain, Ryan K.
dc.contributor.authorAkena, Dickens
dc.contributor.authorNgo, Victoria
dc.contributor.authorNakigudde, Janet
dc.contributor.authorNakku, Juliet
dc.contributor.authorChemusto, Harriet
dc.contributor.authorBeyeza-Kashesya, Jolly
dc.contributor.authorGwokyalya, Violet
dc.contributor.authorFaherty, Laura J.
dc.contributor.authorKyohangirwe, Leticia
dc.contributor.authorKisaakye Nabitaka, Linda
dc.contributor.authorLukwata, Hafsa
dc.contributor.authorLinnemayr, Sebastian
dc.contributor.authorGhosh-Dastidar, Bonnie
dc.contributor.authorBusinge, Juliet
dc.contributor.authorMukasa, Barbara
dc.contributor.authorWanyenze, Rhoda K.
dc.date.accessioned2022-05-22T08:51:55Z
dc.date.available2022-05-22T08:51:55Z
dc.date.issued2019
dc.description.abstractOver one-third of human immunodeficiency virus (HIV)-infected pregnant women are clinically depressed, increasing the risk of mother-to-child transmission (MTCT) of HIV, as well as negative birth and child development outcomes. This study will evaluate the efficacy and cost-effectiveness of an evidence-based stepped care treatment model for perinatal depression (maternal depression treatment in HIV [M-DEPTH]) to improve adherence to prevention of MTCT care among HIV+ women in Uganda. Methods: Eight antenatal care (ANC) clinics in Uganda will be randomized to implement either M-DEPTH (n=4) or usual care (n=4) for perinatal depression among 400 pregnant women (n=50 per clinic) between June 2019 and August 2022. At each site, women who screen positive for potential depression will be enrolled and followed for 18 months post-delivery, assessed in 6-month intervals: baseline, within 1 month of child delivery or pregnancy termination, and months 6, 12, and 18 following delivery. Primary outcomes include adherence to the prevention of mother-to-child transmission (PMTCT) care continuum—including maternal antiretroviral therapy and infant antiretrovial prophylaxis, and maternal virologic suppression; while secondary outcomes will include infant HIV status, post-natal maternal and child health outcomes, and depression treatment uptake and response. Repeated-measures multivariable regression analyses will be conducted to compare outcomes between M-DEPTH and usual care, using 2-tailed tests and an alpha cut-off of P <.05. Using a micro-costing approach, the research team will relate costs to outcomes, examining the incremental cost-effectiveness ration (ICER) of M-DEPTH relative to care as usual. Discussion: This cluster randomized controlled trial will be one of the first to compare the effects of an evidence-based depression care model versus usual care on adherence to each step of the PMTCT care continuum. If determined to be efficacious and costeffective, this study will provide a model for integrating depression care into ANC clinics and promoting adherence to PMTCT.en_US
dc.identifier.citationWagner, G. J., McBain, R. K., Akena, D., Ngo, V., Nakigudde, J., Nakku, J., ... & Wanyenze, R. K. (2019). Maternal depression treatment in HIV (M-DEPTH): study protocol for a cluster randomized controlled trial. Medicine, 98(27). http://dx.doi.org/10.1097/MD.0000000000016329en_US
dc.identifier.urihttp://dx.doi.org/10.1097/MD.0000000000016329
dc.identifier.urihttps://nru.uncst.go.ug/handle/123456789/3279
dc.language.isoenen_US
dc.publisherMedicineen_US
dc.subjectARTen_US
dc.subjectDepressionen_US
dc.subjectHIVen_US
dc.subjectMental healthen_US
dc.subjectPMTCTen_US
dc.subjectPregnancyen_US
dc.subjectUgandaen_US
dc.titleMaternal depression treatment in HIV (M-DEPTH) Study protocol for a cluster randomized controlled trialen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Maternal depression treatment in HIV (M-DEPTH).pdf
Size:
518.89 KB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: